HOFSETH BIOCARE ASA financial statements, including revenue, expenses, profit, and loss

The total revenue of HBCO for the last quarter is 67.61 M NOK, and it's 6.34% lower compared to the previous quarter. The net income of Q3 24 is -35.01 M NOK.